Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma in Relapse

Explore clinical trials studying Multiple Myeloma in Relapse. Study availability and eligibility vary by location and protocol.

57 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma in Relapse trial results

Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT07096778

Conditions
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Locations
  • University of California, San Francisco San Francisco, California, United States
  • H Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • American Oncology Partners, PA Bethesda, Maryland, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT07075185

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +24 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Palo Alto, California, United States
  • UCSF San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Recruiting

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

NCT05853965

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University Medical Center Hamburg-Eppendorf Hamburg, Ham, Germany
  • Klinikum Chemnitz Chemnitz, Germany
  • Uniklinik Heidelberg Heidelberg, Germany
  • UKSH Lübeck Lübeck, Germany
View Trial Details

Related conditions